Your browser doesn't support javascript.
loading
Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.
Pratt, Nicole; Chan, Esther W; Choi, Nam-Kyong; Kimura, Michio; Kimura, Tomomi; Kubota, Kiyoshi; Lai, Edward Chia-Cheng; Man, Kenneth K C; Ooba, Nobuhiro; Park, Byung-Joo; Sato, Tsugumichi; Shin, Ju-Young; Wong, Ian C K; Kao Yang, Yea-Huei; Roughead, Elizabeth E.
Afiliación
  • Pratt N; Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, Australia.
  • Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Choi NK; Medical Research Collaborating Centre, Seoul National University College of Medicine/Seoul National University Hospital, Seoul, South Korea.
  • Kimura M; Department of Medical Informatics, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Kimura T; Department of Medical Informatics, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Kubota K; Department of Pharmacoepidemiology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Lai EC; Institute of Clinical Pharmacy and Pharmaceutical Sciences, Health Outcome Research Centre, National Cheng Kung University, Tainan City, Taiwan.
  • Man KK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Ooba N; Department of Pharmacoepidemiology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Park BJ; Department of Preventative Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Sato T; Korea Institute of Drug Safety and Risk Management, Seoul, South Korea.
  • Shin JY; Department of Pharmacoepidemiology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Wong IC; Korea Institute of Drug Safety and Risk Management, Seoul, South Korea.
  • Kao Yang YH; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Roughead EE; Institute of Clinical Pharmacy and Pharmaceutical Sciences, Health Outcome Research Centre, National Cheng Kung University, Tainan City, Taiwan.
Pharmacoepidemiol Drug Saf ; 24(8): 858-64, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25907076

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Bases de Datos Factuales / Sistemas de Registro de Reacción Adversa a Medicamentos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia / Oceania Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prescripciones de Medicamentos / Bases de Datos Factuales / Sistemas de Registro de Reacción Adversa a Medicamentos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia / Oceania Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Australia